Outcome of Board Meeting

Related Party TransactionsPat NegativeResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.7%1-day move

₹193.85

prior close

₹193.85

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0-0.5-0.5-0.5+0.7-0.4-4.6-8.1-10.8-15.6-9.2+8.8——

Up moveDown movePending

AI summary

Ambar Protein Industries reported FY2026 revenue of ₹50,065.59 Lakhs, up 18.94% from ₹42,162.30 Lakhs in FY2025. However, profit after tax declined 27.2% to ₹702.66 Lakhs from ₹965.02 Lakhs, mainly due to a sharp rise in cost of materials consumed (₹48,777 vs ₹39,502 Lakhs). Basic EPS dropped to ₹12.22 per share from ₹16.78. The statutory auditor issued an unmodified opinion with no qualifications. The board re-appointed Rajendra Natverlal Shah & Co. as Internal Auditor for FY 2026-27 and approved related party transactions with Ankur Oil Industries for sale of goods and job work, subject to shareholder approval.

Likely market impact

Revenue growth is healthy at ~19% but profit decline of 27% signals margin pressure from raw material costs. The related party transaction with Ankur Oil Industries requires shareholder scrutiny. Unmodified auditor opinion is a positive sign.